High-dose oral therapy (10002000 micrograms daily) can effectively treat deficiency even in those with impaired intrinsic factor-mediated absorption, relying on passive diffusion
It has actual human data in neuropathic settings, a defined receptor target, and a safety profile that has at least been examined in a structured way
FDAs March 14, 2025 Final Guidance on Research-Grade Biological Compounds presumes residential shipping or dosing instructions equal intent for human use regardless of labeling
In practical terms: once-daily SubQ injection of 12 mg is the most common protocol, prioritizing consistency over peak concentration
Storage and Handling Store the lyophilized peptide at -20C in a dry, dark environment, protected from moisture and light
Administration Injection or oral Downtime Minimal We will explain known benefits and limits and review your medical history to ensure suitability